Evaluation of pharmacological relaxation effect of the natural product naringin on in vitro cultured airway smooth muscle cells and in vivo ovalbumin-induced asthma Balb/c mice

Wang,Yue; Lu,Yun; Luo,Mingzhi; Shi,Xiaohao; Pan,Yan; Zeng,Huilong; Deng,Linhong

doi:10.3892/br.2016.797

Evaluation of pharmacological relaxation effect of the natural product naringin on in vitro cultured airway smooth muscle cells and in vivo ovalbumin-induced asthma Balb/c mice

Authors:
- Yue Wang
- Yun Lu
- Mingzhi Luo
- Xiaohao Shi
- Yan Pan
- Huilong Zeng
- Linhong Deng
View Affiliations

Affiliations: Changzhou Key Laboratory of Respiratory Medical Engineering, Institute of Biomedical Engineering and Health Sciences, Changzhou University, Changzhou, Jiangsu 213164, P.R. China
Published online on: November 1, 2016 https://doi.org/10.3892/br.2016.797
Pages: 715-722

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asthma has become a common chronic respiratory disease worldwide and its prevalence is predicted to continue increasing in the next decade, particularly in developing countries. A key component in asthma therapy is to alleviate the excessive bronchial airway narrowing ultimately due to airway smooth muscle contraction, which is often facilitated by a smooth muscle relaxant, such as the β2‑adrenergic agonists. Recently, bitter taste receptor (TAS2R) agonists, including saccharin and chloroquine, have been found to potently relax the airway smooth muscle cells (ASMCs) via intracellular Ca2+ signaling. This inspires a great interest in screening the vast resource of natural bitter substances for potential bronchodilatory drugs. In the present study, the relaxation effect of naringin, a compound extracted from common grapefruit, on ASMCs cultured in vitro or bronchial airways of Balb/c mice in vivo was evaluated. The results demonstrated that, when exposed to increasing doses of naringin (0.125, 0.25, 0.5 and 1.0 mM), the traction force generated by the cultured ASMCs decreased progressively, while the intracellular calcium flux signaling in the ASMCs increased. When inhaled at increasing doses (15, 30 and 60 µg), naringin also dose‑dependently reduced the bronchial airway resistance of the normal and ovalbumin‑induced asthma Balb/c mice in response to challenge with methacholine. In conclusion, these findings indicate that naringin was able to effectively relax murine ASMCs in vitro and in vivo, thus suggesting that it is a promising drug agent to be further investigated in the development of novel bronchodilators for the treatment of asthma.

View Figures

View References

1	Alotaibi, GhaziAbdulrahman: Asthma control and self-management: The role of asthma education. Saudi J Health Sci. 4:16–22. 2015. View Article : Google Scholar
2	Al Frayh AR, Shakoor Z, Gad El Rab MO and Hasnain SM: Increased prevalence of asthma in Saudi Arabia. Ann Allergy Asthma Immunol. 86:292–296. 2001. View Article : Google Scholar : PubMed/NCBI
3	Centers for Disease Control and Prevention (CDC), . 2012 National Health Interview Survey (NHIS) Data. http://www.cdc.gov/asthma/nhis/2012/data.htm
4	Albazzaz MK and Patel KR: Effect of azelastine on bronchoconstriction induced by histamine and leukotriene C4 in patients with extrinsic asthma. Thorax. 43:306–311. 1988. View Article : Google Scholar : PubMed/NCBI
5	Fredberg JJ: Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res. 5:22004. View Article : Google Scholar : PubMed/NCBI
6	Hershenson MB, Brown M, Camoretti-Mercado B and Solway J: Airway smooth muscle in asthma. Annu Rev Pathol. 3:523–555. 2008. View Article : Google Scholar : PubMed/NCBI
7	King GG, Paré PD and Seow CY: The mechanics of exaggerated airway narrowing in asthma: The role of smooth muscle. Respir Physiol. 118:1–13. 1999. View Article : Google Scholar : PubMed/NCBI
8	Weaver J: How bitter medicine could clear up asthma. PLoS Biol. 11:e10015002013. View Article : Google Scholar : PubMed/NCBI
9	Grassin-Delyle S, Abrial C, Fayad-Kobeissi S, Brollo M, Faisy C, Alvarez JC, Naline E and Devillier P: The expression and relaxant effect of bitter taste receptors in human bronchi. Respir Res. 14:1342013. View Article : Google Scholar : PubMed/NCBI
10	Deshpande DA, Wang WC, McIlmoyle EL, Robinett KS, Schillinger RM, An SS, Sham JS and Liggett SB: Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med. 16:1299–1304. 2010. View Article : Google Scholar : PubMed/NCBI
11	Xie R, Wen S, Li Y, Zuo C and Zhang J: Study on the antiinflammation and analgesia of naringin. J Hunan Normal Univ (Med Sci). 85–8. (12)2011.
12	Luo YL, Zhang CC, Li PB, Nie YC, Wu H, Shen JG and Su WW: Naringin attenuates enhanced cough, airway hyperresponsiveness and airway inflammation in a guinea pig model of chronic bronchitis induced by cigarette smoke. Int Immunopharmacol. 13:301–307. 2012. View Article : Google Scholar : PubMed/NCBI
13	Hirst SJ: Airway smooth muscle cell culture: Application to studies of airway wall remodelling and phenotype plasticity in asthma. Eur Respir J. 9:808–820. 1996. View Article : Google Scholar : PubMed/NCBI
14	Durand-Arczynska W, Marmy N and Durand J: Caldesmon, calponin and alpha-smooth muscle actin expression in subcultured smooth muscle cells from human airways. Histochemistry. 100:465–471. 1993. View Article : Google Scholar : PubMed/NCBI
15	Dembo M and Wang YL: Stresses at the cell-to-substrate interface during locomotion of fibroblasts. Biophys J. 76:2307–2316. 1999. View Article : Google Scholar : PubMed/NCBI
16	Pelham RJ Jr and Wang Y: Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA. 94:13661–13665. 1997. View Article : Google Scholar : PubMed/NCBI
17	Wang N, Tolić-Nørrelykke IM, Chen J, Mijailovich SM, Butler JP, Fredberg JJ and Stamenović D: Cell prestress. I. Stiffness and prestress are closely associated in adherent contractile cells. Am J Physiol Cell Physiol. 282:C606–C616. 2002. View Article : Google Scholar : PubMed/NCBI
18	Tolić-Nørrelykke IM, Butler JP, Chen J and Wang N: Spatial and temporal traction response in human airway smooth muscle cells. Am J Physiol Cell Physiol. 283:C1254–C1266. 2002. View Article : Google Scholar : PubMed/NCBI
19	Yang XR, Lin MJ, Yip KP, Jeyakumar LH, Fleischer S, Leung GP and Sham JS: Multiple ryanodine receptor subtypes and heterogeneous ryanodine receptor-gated Ca2+ stores in pulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 289:L338–L348. 2005. View Article : Google Scholar : PubMed/NCBI
20	Remillard CV, Zhang WM, Shimoda LA and Sham JSK: Physiological properties and functions of Ca(2+) sparks in rat intrapulmonary arterial smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 283:L433–L444. 2002. View Article : Google Scholar : PubMed/NCBI
21	Chen H, Cheng S, Wang A, Bunjhoo H, Cao Y, Xie J, Wang C, Xu Y and Xiong W: IL-21 does not involve in OVA-induced airway remodeling and chronic airway inflammation. Int J Clin Exp Med. 8:10640–10645. 2015.PubMed/NCBI
22	Zhang CH, Li Y, Zhao W, Lifshitz LM, Li H, Harfe BD, Zhu MS and ZhuGe R: The transmembrane protein 16A Ca(2+)-activated Cl- channel in airway smooth muscle contributes to airway hyperresponsiveness. Am J Respir Crit Care Med. 187:374–381. 2013. View Article : Google Scholar : PubMed/NCBI
23	Jie Z, Jin M, Cai Y, Bai C, Shen Y, Yuan Z, Hu Y and Holgate S: The effects of Th2 cytokines on the expression of ADAM33 in allergen-induced chronic airway inflammation. Respir Physiol Neurobiol. 168:289–294. 2009. View Article : Google Scholar : PubMed/NCBI
24	Song A, Liao Q, Li J, Lin F, Liu E, Jiang X and Deng L: Chronic exposure to sulfur dioxide enhances airway hyperresponsiveness only in ovalbumin-sensitized rats. Toxicol Lett. 214:320–327. 2012. View Article : Google Scholar : PubMed/NCBI
25	Zhang YJ, Wang YN, Ding YJ, He LY, Liu X and Kang QZ: Establishment of bronchial asthma model induced with OVA. Henan Medical Research. 21:268–270. 2012.
26	Jonasson S, Hjoberg J, Hedenstierna G and Basu S: Allergen-induced formation of F2-isoprostanes in a murine asthma model identifies oxidative stress in acute airway inflammation in vivo. Prostaglandins Leukot Essent Fatty Acids. 80:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
27	Meyerhof W, Batram C, Kuhn C, Brockhoff A, Chudoba E, Bufe B, Appendino G and Behrens M: The molecular receptive ranges of human TAS2R bitter taste receptors. Chem Senses. 35:157–170. 2010. View Article : Google Scholar : PubMed/NCBI
28	Zeng HL, Wang Y, Luo MZ, Shi XH, Lu Y, Pan Y and Deng LH: Bitter taste receptor agonist (Quinine) induces traction force reduction and calcium flux increase in airway smooth muscle cells from ovalbumin-sensitized and challenged rats. J Adv Biomed Eng Technol. 2:20–27. 2015. View Article : Google Scholar
29	Billington CK and Penn RB: Signaling and regulation of G protein-coupled receptors in airway smooth muscle. Respir Res. 4:22003. View Article : Google Scholar : PubMed/NCBI
30	Pulkkinen V, Manson ML, Säfholm J, Adner M and Dahlén SE: The bitter taste receptor (TAS2R) agonists denatonium and chloroquine display distinct patterns of relaxation of the guinea pig trachea. Am J Physiol Lung Cell Mol Physiol. 303:L956–L966. 2012. View Article : Google Scholar : PubMed/NCBI
31	An SS, Wang WC, Koziol-White CJ, Ahn K, Lee DY, Kurten RC, Panettieri RA Jr and Liggett SB: TAS2R activation promotes airway smooth muscle relaxation despite β(2)-adrenergic receptor tachyphylaxis. Am J Physiol Lung Cell Mol Physiol. 303:L304–L311. 2012. View Article : Google Scholar : PubMed/NCBI
32	Townsend EA, Yim PD, Gallos G and Emala CW: Can we find better bronchodilators to relieve asthma symptoms? J Allergy (Cairo). 2012.3219492012.PubMed/NCBI
33	Clifford RL and Knox AJ: Future bronchodilator therapy: A bitter pill to swallow? Am J Physiol Lung Cell Mol Physiol. 303:L953–L955. 2012. View Article : Google Scholar : PubMed/NCBI
34	Behrens M, Brockhoff A, Kuhn C, Bufe B, Winnig M and Meyerhof W: The human taste receptor hTAS2R14 responds to a variety of different bitter compounds. Biochem Biophys Res Commun. 319:479–485. 2004. View Article : Google Scholar : PubMed/NCBI
35	Guihua X, Shuyin L, Jinliang G and Wang S: Naringin protects ovalbumin-induced airway inflammation in a mouse model of asthma. Inflammation. 39:891–899. 2016. View Article : Google Scholar : PubMed/NCBI
36	Jiao HY, Su WW, Li PB, Liao Y, Zhou Q, Zhu N and He LL: Therapeutic effects of naringin in a guinea pig model of ovalbumin-induced cough-variant asthma. Pulm Pharmacol Ther. 33:59–65. 2015. View Article : Google Scholar : PubMed/NCBI